Skip to main content
NXL
NASDAQ Industrial Applications And Services

Nexalin Secures $15M Equity Line with Alumni Capital and Adds $750K Direct Offering

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.325
Mkt Cap
$7.285M
52W Low
$0.305
52W High
$2
52W Position info
6.6% above low
Off High info
84% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

NXL is trading near its 52-week low of $0.305 (6.6% above the low) on light trading volume (0.2× avg).

Summary

Nexalin Technology entered a $15 million equity line with Alumni Capital and raised $750,000 in a direct offering, providing capital but adding dilution risk.


Key Events · Financing and Capital Events · NXL

  • $15M Equity Line Established

    Under an Any Market Purchase Agreement with Alumni Capital LP, Nexalin can sell up to $15 million of common stock at a discount to market over the term ending December 31, 2027.

  • $750K Direct Offering Priced

    The company sold 2,419,355 shares at $0.31 per share in a registered direct offering, raising approximately $750,000 before expenses, with 1,209,677 warrants exercisable at $0.50 per share.

  • Commitment Fee and Advisory Costs

    Nexalin agreed to pay a 2% commitment fee ($300,000) to Alumni Capital, payable in cash or shares, and a $100,000 non-refundable advisory fee to Maxim Group LLC.

  • Discount Pricing Mechanics

    Under the equity line, Alumni Capital purchases shares at 92% of the 3-day VWAP or 97% of the prior-day low, providing capital but at a discount to market.


Analysis · NXL · Industrial Applications And Services

A $15 million equity line of credit from Alumni Capital LP gives Nexalin Technology the right to sell shares at a discount to market over the next 16 months, providing much-needed capital runway for a company facing a going concern warning and Nasdaq delisting proceedings. The deal also includes a $750,000 direct offering at $0.31 per share with warrants, and a $100,000 advisory fee to Maxim Group. However, the discount pricing and potential dilution are significant for existing shareholders.

How filings like this one have moved

In the 30 days to Oct 20, 2026, 37.4% of the 952 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NXL was trading at $0.33 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.3M. The 52-week trading range was $0.31 to $2.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NXL - Latest Insights

NXL
Oct 08, 2026, 5:01 PM EDT
Filing Type: S-1/A
Importance Score:
7
Price at Filing: $4.00
Real-time Price: $2.23 info
Change: -$1.77 (-44%) info
Market Cap: $2.34M info
NXL
Oct 08, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.44
Real-time Price: $2.23 info
Change: -$2.21 (-50%) info
Market Cap: $2.34M info
NXL
Oct 01, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.02
Real-time Price: $2.23 info
Change: -$5.78 (-72%) info
Market Cap: $2.34M info
NXL
Oct 01, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $6.73
Real-time Price: $2.23 info
Change: -$4.50 (-67%) info
Market Cap: $2.34M info
NXL
Sep 28, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.27
Real-time Price: $2.23 info
Change: -$2.04 (-48%) info
Market Cap: $2.34M info